CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
about
Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 GenePhylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and JapanPopulation structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.Comprehensive Diagnosis of Bacterial Infection Associated with Acute Cholecystitis Using Metagenomic ApproachGenomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium InfectionCTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.Characterization of a P1-like bacteriophage carrying CTX-M-27 in Salmonella spp. resistant to third generation cephalosporins isolated from pork in China.Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.Escherichia coli ST131: a multidrug-resistant clone primed for global domination.Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains.Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world.Whole-Genome Analysis of Antimicrobial-Resistant and Extraintestinal Pathogenic Escherichia coli in River Water.ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015.Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014.Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital.An update on faecal carriage of ESBL-producing Enterobacteriaceae by Portuguese healthy humans: detection of the H30 subclone of B2-ST131 Escherichia coli producing CTX-M-27.Genetic Platforms of blaCTX-M in Carbapenemase-Producing Strains of K. pneumoniae Isolated in Chile.Escherichia coli ST131-22 as a Foodborne Uropathogen
P2860
Q28112087-443D3BB1-BADC-422F-899C-A47073D10FDAQ30354365-E0A4FACC-AFAD-4A96-9119-14A92E4CC62CQ30395087-CF8F329E-2411-404C-8B87-7F3EFD3D758FQ30397339-CFAC4D28-65C9-43F0-9F78-6B40950A01F7Q30402760-7E4BD49E-E34B-44DC-92F4-DF6A3C82C8D6Q33581179-B51F738D-82EC-4ABE-B0DC-A3D65DC0BB96Q33706348-4C5CFC8A-F2B1-48BD-B1F7-9B20601DDDE9Q33806382-0F056DCC-3637-4964-93D5-21D51E96D0D6Q36727688-E8840F9F-3677-4342-8BB0-C42229A6EFEBQ37428648-EDC4ACA4-3462-4434-82E4-14FB9ABDCF6CQ37538628-6649FF91-AB61-4B95-8CAF-FC2D57E374CAQ37591141-1CE21D42-0405-4D82-ABB9-A393E50E936EQ37612974-3F9AD15F-F47C-4BB0-AB88-323EC9633FF7Q39201659-C0B34FDB-935F-4A70-99A1-4F2973DEE00FQ40171775-CDE27074-59A8-4B66-867F-8838A8298572Q40190138-E5006F63-99D0-4224-88DF-6D379E08905BQ40196563-36EB0289-D3FE-4CDE-BD3F-A2235950A90BQ40406138-48DE7302-C831-4C94-ACC1-C79B90ED4883Q40688540-F77F858C-E531-41C3-8541-7D8C4A5700DEQ41372349-1A77AEA7-267F-4739-A237-95E151D829ACQ42358844-68CFDAEA-817C-41CA-96EF-E0F0A6E4EB0BQ47123962-0523F147-3E8E-4798-805C-AE3A7C5EF0C9Q54253320-8D1D5102-7CDB-4EE3-88F0-0A546AB9E266Q55312814-4968B351-3FF6-4202-BC1E-F1F66D36772BQ58699289-3543E89E-642A-4398-B0B4-A9EA45893246
P2860
CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CTX-M-27- and CTX-M-14-produci ...... panese regional ESBL epidemic.
@en
type
label
CTX-M-27- and CTX-M-14-produci ...... panese regional ESBL epidemic.
@en
prefLabel
CTX-M-27- and CTX-M-14-produci ...... panese regional ESBL epidemic.
@en
P2093
P2860
P356
P1476
CTX-M-27- and CTX-M-14-produci ...... panese regional ESBL epidemic.
@en
P2093
James R Johnson
Kyoto-Shiga Clinical Microbiology Study Group
Kyoto–Shiga Clinical Microbiology Study Group
Masaki Yamamoto
Michio Tanaka
Miki Nagao
Satoshi Ichiyama
Shunji Takakura
Yasufumi Matsumura
P2860
P304
P356
10.1093/JAC/DKV017
P407
P577
2015-02-16T00:00:00Z